GENI fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
GENinCode Plc engages in the genetic risk assessment of cardiovascular disease. It provides predictive analysis of risk to a patient’s health based on their genes. It operates through the Spain, Italy, France, Germany, United Kingdom, and Rest of the World. The Rest of the World segment includes Chile, Sweden, Mexico, and Peru. The company was founded by Matthew Heaton Walls and Jordi Puig Gilberte on September 6, 2018 and is headquartered in Manchester, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
GENI does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company